
CDC Panel Recommends Merck's RSV Vaccine for Infants
The CDC's Advisory Committee on Immunization Practices recommended Merck's RSV monoclonal antibody, Enflonsia, for infants, offering a new preventive option against RSV with safety and efficacy demonstrated, potentially impacting public health significantly.
